4-(3-Fluoroazetidin-1-yl)piperidine dihydrochloride, 95.0%, 1g

3-(naphthalen-1-yl)-1,2-oxazol-5-ol, 95.0%, 2g

3-Bromothiophene-2-carboxaldehyde>95.0%(GC)5g

n-Butyl 2,2-difluorocyclopropanecarboxylate, 95.0%, 1g

2-Methoxy-6-(trifluoromethyl)aniline, 95.0%, 5g

{4-ethynylbicyclo[2.2.2]octan-1-yl}methanol, 95+%, 100mg

1-(Difluoromethyl)-4-iodo-1H-pyrazole, 95.0%, 1g

Vinyltrimethoxysilane>98.0%(GC)100mL

4-nitroanthranilic acid, min. 98%, for synthesis, 5 g, glass packaging

3-(Benzyloxy)-2-nitrophenol, 98%, 250mg

4-Bromophthalazin-1(2H)-one, 95.0%, 1g

1,3-Benzoxazol-4-amine, 97.0%, 1g

5-Bromo-1-methylpyrimidine-2,4(1h,3h)-dione, 97%, 100mg